Predictive role of sustained imaging MRD negativity assessed by diffusion-weighted whole-body MRI in multiple myeloma
Am J Hematol
.
2023 Sep;98(9):E230-E232.
doi: 10.1002/ajh.26995.
Epub 2023 Jun 15.
Authors
Angelo Belotti
1
,
Rossella Ribolla
1
,
Claudia Crippa
1
,
Marco Chiarini
2
,
Viviana Giustini
2
,
Samantha Ferrari
1
,
Annalisa Peli
1
,
Chiara Cattaneo
1
,
Aldo Roccaro
3
,
Barbara Frittoli
4
,
Luigi Grazioli
4
,
Giuseppe Rossi
1
,
Alessandra Tucci
1
Affiliations
1
Department of Hematology, ASST Spedali Civili, Brescia, Italy.
2
Clinical Chemistry Laboratory/Diagnostic Department, ASST Spedali Civili, Brescia, Italy.
3
Clinical Trial Center, Translational Research and Phase I Unit, ASST Spedali Civili, Brescia, Italy.
4
Department of Radiology, ASST Spedali Civili, Brescia, Italy.
PMID:
37317959
DOI:
10.1002/ajh.26995
No abstract available
MeSH terms
Diffusion Magnetic Resonance Imaging / methods
Humans
Multiple Myeloma* / diagnostic imaging
Multiple Myeloma* / therapy
Neoplasm, Residual